Ivosidenib is made to stop the IDH1 enzyme, which is a big deal for AML that keeps coming back or doesn’t respond to treatment. It’s super-focused on patients who have that IDH1 glitch. The way it works is by zeroing in on the wonky IDH1 enzyme, kind of like a radar for the cancer cells’ party.
The drug comes in tablet form, like the kind you’d find in a pill bottle, and each one is 250 mg. The doctor usually suggests you take 500 mg of this stuff every day, and you’ll swallow it whole. You’ll get 60 tablets in each bottle of this stuff.
Reviews
There are no reviews yet.